UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including
area code:
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
None | None | None |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 8.01. Other Events.
On October 5, 2021, the board of directors of Augmedix, Inc. (the “Company”) appointed Jason Krikorian to the audit committee of the board of directors, replacing Emmanuel Krakaris on the audit committee. As a result of Mr. Krikorian’s appointment to the audit committee, the Company has a fully independent audit committee under Rule 10A-3(b)(1) of the Exchange Act and the Nasdaq Stock Market’s corporate governance rules. The Company’s board of directors has determined that Mr. Krikorian satisfies the independence requirements even though he falls outside the “safe harbor” definition set forth in Rule 10A-3(e)(1)(ii) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as Mr. Krikorian is a general partner of DCM VI, L.P., which is an affiliate of entities that collectively own in excess of 10% of the Company’s outstanding common stock.
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AUGMEDIX, INC. | |||
By: | /s/ PAUL GINOCCHIO | ||
Name: | Paul Ginocchio | ||
Title: | Chief Financial Officer | ||
Date: October 6, 2021 |
2
Cover |
Oct. 05, 2021 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Oct. 05, 2021 |
Entity File Number | 000-56036 |
Entity Registrant Name | AUGMEDIX, INC. |
Entity Central Index Key | 0001769804 |
Entity Tax Identification Number | 83-3299164 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 111 Sutter Street |
Entity Address, Address Line Two | Suite 1300 |
Entity Address, City or Town | San Francisco |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94104 |
City Area Code | (888) |
Local Phone Number | 649-4885 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | false |
Entity Information, Former Legal or Registered Name | None |
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end
6_#JO:)DPUWR_CY3U&QA9]XL*R:*O7H#-6/"<&?@8K_Z+J,6V5
MQ4_$8KJ*#9]Q+J]GC%4^S(4E;/A65DA96*$+W2 P'?!+XP:V_9V*GU!6W"R2;XX-V>84PIY)*>@^>^"'=.+9XCFK%XLQ$9/A$UC.?"7=C'D1QFI;0LGHYB(P
M@_19V 9 'X]T8UIX[93PLF',>X;QUM(A935Y#<8QO8J''7$XY'NK?/>]F?HT
MVNG,N
M&_IUKZ/V>E?DQNY/R[?=F\D_Y'%@YC2YW+V]T